Vivacelle Bio, Inc. — Form D/A

Vivacelle Bio, Inc. of Evanston, IL, a company, filed a Form D amendment with the SEC on 2019-02-11. The offering totals $3.4M, of which $2.9M was reported sold. Industry: Other Technology.

Offering

Issuer

Officers, directors & promoters (23)

NameRoleLocation
Ron DamperDirectorEvanston, IL
Harven DeShieldDirectorEvanston, IL
Cuthbert SimpkinsDirectorEvanston, IL
Diane SimpkinsDirectorEvanston, IL
Harven DeShieldExecutive OfficerEvanston, IL
Cuthbert SimpkinsExecutive OfficerEvanston, IL
Diane SimpkinsExecutive OfficerEvanston, IL
Krishna TalluriExecutive OfficerEvanston, IL
Stephen KeithDirectorToronto, A6
Stephen KeithExecutive OfficerToronto, A6
Paul BurtonDirectorChicago, IL
Paul BurtonExecutive OfficerChicago, IL
Krishna TalluriDirectorEvanston, IL
Ron Ormand DamperDirectorChicago, IL
Harven Ormand DeShieldDirectorChicago, IL
Harven Ormand DeShieldExecutive OfficerChicago, IL
Stephen Ormand KeithDirectorChicago, IL
Stephen Ormand KeithExecutive OfficerChicago, IL
Cuthbert Ormand SimpkinsDirectorChicago, IL
Cuthbert Ormand SimpkinsExecutive OfficerChicago, IL
Diane Ormand SimpkinsDirectorChicago, IL
Diane Ormand SimpkinsExecutive OfficerChicago, IL
Edward NicholsExecutive OfficerShreveport, LA

Other filings by this issuer (5)

FiledFormOfferingSold
2018-03-13D/A$1.5M$514K
2016-09-09D/A$1.3M$1.3M
2016-08-17D$1.5M$100K
2014-08-08D/A$550K$550K
2014-02-13D$1.0M$225K

More